Haleon plc

Research Haleon plc (HLN) on Bullrun: market cap USD 41.55B, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHLN
• ExchangeNYSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 41.55B
• Dividend yield2.0%
• Financial periodQ4 2025
• RevenueUSD 11.03B
• Net incomeUSD 1.67B
• Free cash flowUSD 2.22B
• Gross margin64.2%

Valuation Snapshot

latest market cap is USD 41.55B; dividend yield is 2.0%.

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Frequently asked questions

What is Haleon plc's market cap?

Haleon plc's market capitalization is USD 41.55B.

Does Haleon plc pay a dividend?

Haleon plc has a dividend yield of 2.0%.

What does Haleon plc do?

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.